These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7871095)

  • 1. Brain uptake and distribution of the potential memory enhancer CL 275,838 and its main metabolites in rats: relationship between brain concentrations and in vitro potencies on neurotransmitter mechanisms.
    Caccia S; Confalonieri S; Guiso G; Bernasconi P; Cagnotto A; Skorupska M; Mennini T
    Psychopharmacology (Berl); 1994 Aug; 115(4):502-8. PubMed ID: 7871095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics and safety of a potential memory-enhancing compound, CL 275,838, in healthy male volunteers.
    Caccia S; Confalonieri S; Guiso G; Lucca U; Parma E; Guido M; Tettamanti M; Tiraboschi P; Spagnoli A
    J Clin Pharmacol; 1994 Jul; 34(7):748-53. PubMed ID: 7929869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal metabolism of the potential memory-enhancing agent, CL 275,838, to its desbenzyl derivative.
    Ferrarese A; de Palma F; Celeste S; Marini PP; Caccia S
    Xenobiotica; 1993 Sep; 23(9):1007-16. PubMed ID: 8291260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose safety and pharmacokinetics of a potential cognition-enhancing compound, CL 275,838, in healthy volunteers.
    Caccia S; Confalonieri S; Guiso G; Lucca U; Parma E; Guido M; Tettamanti M; Tiraboschi P; Spagnoli A
    J Clin Pharmacol; 1993 Sep; 33(9):845-50. PubMed ID: 8227482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography of the potential memory-enhancing agent CL 275,838 and its main metabolites, using a post-column photochemical reactor and fluorimetric detection.
    Caccia S; Confalonieri S; Guiso G; Celeste S; Marini PP
    J Chromatogr; 1992 Oct; 581(1):109-17. PubMed ID: 1429992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.
    van Beijsterveldt LE; Geerts RJ; Leysen JE; Megens AA; Van den Eynde HM; Meuldermans WE; Heykants JJ
    Psychopharmacology (Berl); 1994 Feb; 114(1):53-62. PubMed ID: 7531352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular uptake disguises action of L-glutamate on N-methyl-D-aspartate receptors. With an appendix: diffusion of transported amino acids into brain slices.
    Garthwaite J
    Br J Pharmacol; 1985 May; 85(1):297-307. PubMed ID: 2862941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the putative anxiolytic SM-3997 on central monoaminergic systems.
    Tatsuno T; Shimizu H; Hirose A; Tanaka H; Kumasaka Y; Nakamura M
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1049-55. PubMed ID: 2572002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.
    Caccia S; Bizzi A; Coltro G; Fracasso C; Frittoli E; Mennini T; Garattini S
    J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
    Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
    Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
    Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]D-2-amino-5-phosphonopentanoate as a ligand for N-methyl-D-aspartate receptors in the mammalian central nervous system.
    Olverman HJ; Jones AW; Watkins JC
    Neuroscience; 1988 Jul; 26(1):1-15. PubMed ID: 2901689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ergolines on neurotransmitter systems in the rat brain.
    Moretti A; Carfagna N; Caccia C; Carpentieri M
    Arch Int Pharmacodyn Ther; 1988; 294():33-45. PubMed ID: 2906797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
    Potschka H; Fedrowitz M; Löscher W
    Eur J Pharmacol; 1999 Jun; 374(2):175-87. PubMed ID: 10422758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the methylpiperazinopyridobenzoxazepine derivative JL13, a potential antipsychotic, in rat brain.
    Guiso G; Caccia S
    J Pharm Pharmacol; 2001 Mar; 53(3):317-21. PubMed ID: 11291746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.